<p>2022年１月被診斷出乳癌，經歷了開刀、重建、標靶跟化療後，發現我有很多朋友祝福，及陌生癌友的關心，讓我在面對癌症的過程中不那麼恐懼，因此希望透過這個頻道，陪伴也正在癌症痛苦中的你，徬徨想哭時知道自己並不孤單... <br /> <br />------------ 觀眾提問統一回覆區------------ <br />1. 醫師貴人是誰？高雄大同醫院/高理均醫師 <br />2. 高醫師有比蘇志燮帥嗎？開刀房聽到蘇醫師那一刻有比蘇志燮帥！ <br />3. 瞇拜拜的廟？高雄左營城隍廟 <br />4. 義乳現在還好嗎？她現在越來越好～甚至比剩乳？還豐彈，謝謝大家關心 <br /> <br/>Powered by <a href="https://firstory.me">Firstory Hosting</a></p>
Language
🇨🇳
Publishing Since
6/28/2022
Email Addresses
1 available
Phone Numbers
0 available
October 3, 2022
<p>這集講到前四次化療的過程。以前我很羨慕乾性皮膚的人，因為我皮膚很油看起來毛孔大容易髒髒的，但這次化療體驗到夢寐以求的乾性皮膚後，突然就開始懷念起我的油性肌... <br />． <br />#FB社團：花漾女孩GOGOGO <br />#美國小詩：每個人都有自己的時區 <br />化療藥 #微脂體小紅莓 #癌得星 #歐洲紫杉醇 <br />． <br />💟 贊助阿瞇買夢想：<a href="https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9" target="_blank">https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9</a> <br />💟 祝福並和我說說話： <a href="https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments" target="_blank">https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments</a> <br /> —感謝聆聽的所有朋友，陪伴你，我覺得很幸福— <br />． <br />【 聯絡瞇瞇：[email protected] 】 <br /> <br /></p> <br /> <br/>Powered by <a href="https://firstory.me">Firstory Hosting</a>
September 16, 2022
<p>因為化療需要從人工血管上放針，遠看著，居然可以加深我鎖骨的線條耶！真的很感謝醫師貴人賜與我的鎖骨:) <br />． <br />—何則文/成就未來的你— <br />「把簡單的事情，做到一個意料之外的高度，更能凸顯創意與用心」 <br />>>><a href="https://www.books.com.tw/products/0010862622" target="_blank">https://www.books.com.tw/products/0010862622</a> <br />． <br />💟 贊助阿瞇買夢想：<a href="https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9" target="_blank">https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9</a> <br />💟 祝福並和我說說話： <a href="https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments" target="_blank">https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments</a> <br />． <br />． <br />-------------------------- 觀眾提問 -------------------------- <br /> <br />1. 醫師貴人是誰？高雄大同醫院/高理均醫師 <br />2. 高醫師有比蘇志燮帥嗎？開刀房聽到蘇醫師那一刻有比蘇志燮帥！ <br />3. 瞇拜拜的廟？高雄左營城隍廟 <br />4. 義乳現在還好嗎？他現在越來越好～謝謝大家關心 <br /> <br />化療藥 #微脂體小紅莓 #癌得星 #歐洲紫杉醇 <br /> --------感謝聆聽的所有朋友，陪伴你，我覺得很幸福---------</p> <br /> <br/>Powered by <a href="https://firstory.me">Firstory Hosting</a>
August 31, 2022
<p>沒錯，我就是那個要化療+標靶的三成機率人！一聽到醫師貴人的宣佈我真的在心裡罵了髒話。 <br />． <br />💟 贊助阿瞇買夢想：<a href="https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9" target="_blank">https://pay.firstory.me/user/cl4yaecca038a01xj9nwi0rs9</a> <br />💟 祝福並和我說說話： <a href="https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments" target="_blank">https://open.firstory.me/user/cl4yaecca038a01xj9nwi0rs9/comments</a> <br />． <br /> —感謝聆聽的所有朋友，陪伴你，我覺得很幸福—</p> <br /> <br/>Powered by <a href="https://firstory.me">Firstory Hosting</a>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
